Daicel Corporation (TYO:4202)

Japan flag Japan · Delayed Price · Currency is JPY
1,349.50
-11.00 (-0.81%)
Sep 30, 2025, 3:30 PM JST
-0.81%
Market Cap357.79B
Revenue (ttm)580.23B
Net Income (ttm)42.91B
Shares Out265.13M
EPS (ttm)158.91
PE Ratio8.49
Forward PE6.76
Dividend60.00 (4.41%)
Ex-Dividend DateSep 29, 2025
Volume592,300
Average Volume616,065
Open1,355.00
Previous Close1,360.50
Day's Range1,340.00 - 1,360.00
52-Week Range1,057.50 - 1,482.00
Beta0.20
RSI43.31
Earnings DateNov 6, 2025

About Daicel

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, s... [Read more]

Sector Materials
Founded 1919
Employees 11,178
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4202
Full Company Profile

Financial Performance

In 2024, Daicel's revenue was 586.53 billion, an increase of 5.10% compared to the previous year's 558.06 billion. Earnings were 49.48 billion, a decrease of -11.38%.

Financial Statements

News

There is no news available yet.